Introduction
Several families of extracellular proteins including the netrins, the semaphorins, the ephrins, and the Slits function as Angiogenesis is a cellular process of capillary sprouting and guidance cues to attract or repel projecting axons and migrating configuring of neovasculature. It is of crucial importance in a neurons during the development of the nervous system (Tessiervariety of physiological and pathological conditions, including Lavigne and Goodman, 1996; Dickson, 2002) . Slit is a new family ischemia and hypoxia, wound healing, diabetic retinopathy, of secreted repellents in axon guidance macular degeneration, neovascular glaucoma, psoriasis, rheuBrose et al., 1999; Li et al., 1999) and neuronal matoid arthritis, and cancer growth and metastasis (Hanahan migration . The receptor for Slit is the transmemand Folkman, 1996; Risau, 1997; Holash et al., 1999;  Carmeliet brane protein Roundabout (Robo) (Kidd et al., 1998 Brose and Jain, 2000) . The obligatory requirement of angiogenesis Li et al., 1999) . Slit has recently been shown to be the growth and metastasis of cancers is now well recognized.
an endogenously available inhibitor of leukocyte chemotaxis For instance, the growth of solid tumors requires concomitant ). There are three Slits and four Robos in mamexpansion of vascular networks to maintain the blood supply of mals (for a recent review, see Wong et al., 2002) . Some of the oxygen and nutrients; an insufficient supply of blood (to tissues Slits and Robos are expressed in adult tissues and outside located more than 100 to 200 m away from blood vessels) the nervous system (Holmes et al., 1998; Wu et al., 2001) . For can lead to cancer necrosis. Although vascular endothelial cell example, SLIT2 mRNA in endothelial cells and ROBO1 mRNA growth factors (VEGFs), fibroblast growth factors (FGFs), and in leukocytes have been reported ). However, several other angiogenic molecules are indispensable for vessel it has not been determined whether human cancer cells can formation (Gale and Yancopoulos, 1999; Yancopoulos et al., express these genes, either at the mRNA or protein levels. Po-2000; Folkman, 2001 Kerbel and Folkman, 2002) , the tential roles of Slit-Robo signaling in pathological conditions molecular and cellular mechanisms regulating tumor angiogenesis are still not well understood.
have been suggested ), but not established. We have now investigated whether Slit and Robo could play roles in tumor angiogenesis in vitro and in vivo. Results from our current studies have established that Slit-Robo signaling attracts vascular endothelial cells, which significantly extends the previous conclusion of a fundamentally conserved mechanism for guiding somatic cell migration Rao et al., 2002) . Furthermore, our findings of Slit-Robo signaling in promoting tumor-induced angiogenesis indicate that Slit and Robo play significant roles in pathological conditions. The effectiveness of Robo blockade in limiting tumor growth demonstrates a novel target as well as molecular tools for cancer therapy.
Results

Expression of Slit2 on cancer cells and Robo1 in endothelial cells
Using reverse-transcription coupled to the polymerase chain reaction (RT-PCR), we found that A375 cells, a cell line derived from a human malignant melanoma, expressed SLIT2 mRNA and human umbilical vein endothelial cells (HUVECs) expressed ROBO1 mRNA, respectively ( Figures 1A and 1D ). The expression of SLIT2 mRNA in A375 cells and ROBO1 mRNA in HUVECs was confirmed by Northern blotting with 32 P-labeled SLIT2 and ROBO1 cDNA fragments ( Figures 1B and 1E ). The G3PDH mRNA, a house-keeping gene, was probed as the loading control of total input RNA. We generated antibodies to Slit2 and Robo1 and detected the expression of Slit2 protein in A375 cells ( Figure 1C ) and Robo1 protein in HUVECs ( Figure 1F ). Slit2/293 cells and Robo1/293 cells were used as the positive controls, and V/293 cells were used as the negative controls (Li et al., 1999; Wu et al., 1999; Wu et al., 2001) . The expression of Slit2 in A375 cell derived solid tumors was detected by immunohistochemical staining with the anti-Slit2 antibody, but not with the preimmune IgG ( Figure 1G ). The expression of Robo1, which co-localized with vWF (von Willbrand factor) expression, in tumor endothelial cells was visualized with the anti-Robo1 protein with a higher concentration near the center of the tumor and ROBO1 band ‫005ف(‬ bp), respectively. Human ␤-ACTIN mRNA ‫0.1ف(‬ kb) was also assayed as a control for RT-PCR. P-C (PCR control) lane was PCR in and a lower concentration in the periphery ( Figure 1G ). The the absence of the templates; RT-C (RT control) was PCR using the template expression of Slit2 in malignant melanoma and Robo1 in tumor generated without the reverse transcriptase.
endothelial cells suggests a possible paracrine Slit2/Robo1 in-B and E: Northern blotting of SLIT2 ‫0.5ف(‬ kb) in A375 cells and ROBO1 ‫6.4ف(‬ teraction in the pathogenesis of malignant melanoma. kb) in HUVECs. G3PDH (a house-keeping gene; ‫4.1ف‬ kb) was used as a loading control. C and F: Protein expression of Slit2 in A375 cells ‫002ف(‬ kDa) and Robo1
Cell surface localization of Slit2 and its upregulation ‫002ف(‬ kDa) in HUVECs was detected by anti-Slit2, anti-Robo1, and 9E10
Although Slit2 is predicted to be a soluble protein, it has been Abs, but not by preimmune IgG. Slit2/293 cells and Robo1/293 cells were shown to bind to Glypican-1 and to be localized on the cell used as the positive control while V/293 cells were used as the negative surface in the brain, in a heparan sulfate proteoglycan (HSPG)-control. 9E10 was a monoclonal antibody against the c-myc tag of Slit2 fusion protein.
dependent manner (Liang et al., 1999; Hu, 2001 ; Ronca et al., To explore the molecular mechanism governing the formation of the Slit2 gradient, we examined whether cytokines could regulate Slit2 expression in A375 cells. TNF-␣ (tumor necrosis factor-␣) increased the expression of Slit2 ( Figure 1I ). Similar findings were also observed using IL-1␤ (interleukine-1␤; data 2D-2F). RoboN added in the bath neutralized the Slit2-induced directional migration, but had no inhibitory effect on the bFGFnot shown), indicating that the upregulation of Slit2 in response to the secretion of proinflammatory mediators (and perhaps due induced migration (Figures 2E and 2F) . These data indicate that Slit2 can attract the directional migration of vascular endothelial to hypoxia or expression of oncogenes) could be involved in increasing Slit2 in the center of A375 cell-derived solid tumors, cells through Robo1. thus resulting in the generation of a gradient.
Angiogenic activity of Slit2 and role of Slit2-Robo1 signaling in tumor-induced angiogenesis Attraction of endothelial cells by Slit2 We used several approaches to investigate whether and how
To investigate the potential regulation of angiogenesis by Slit2, we first examined whether Slit2 could induce the differentiation, Slit could regulate the migration of endothelial cells. We first tested whether Slit2 had any chemotactic effects on the migraspecifically tube formation of HUVECs in vitro. Slit2 increased the generation of tubular networks in a dose-dependent manner tion of HUVECs using Boyden chamber assay. Similar to bFGF (basic fibroblast growth factor), purified recombinant human (Figures 2G and 2H) . Preincubation of Slit2 with RoboN ( Figures  2G and 2H ), or preincubation of HUVECs with R5 ( Figure 2I ), Slit2 protein ( Figure 1J ) induced the migration of HUVECs in a dose-dependent manner (Figure 2A) . Preincubation of Slit2 with neutralized the effect of Slit2, resulting in fewer and shorter tube structures. These results indicate that Slit2 has an angiogenic RoboN (an extracellular fragment of Robo1 that is a known inhibitor for the Slit2/Robo1 interaction; Wu et al., 1999 Wu et al., , 2001 activity in vitro. It should be mentioned that Slit2 had no detectable activity on the proliferation of HUVECs (data not shown). or preincubation of HUVECs with R5 (an IgG 2b monoclonal antibody to the first immunoglobulin domain of Robo1), but not Because A375 cells expressed Slit2 and Slit2 induced the migration and the tube formation of endothelial cells in vitro, with an IgG 2b control, significantly neutralized the Slit2-induced migration (Figures 2A and 2B ). In contrast, RoboN or R5 did not we tested the pathological significance of Slit2-Robo1 signaling in tumor angiogenesis using the xenografted animal model. For affect the bFGF-induced migration of HUVECs. These results indicate that Slit2 can promote the migration of HUVECs through this purpose, we transfected A375 cells with the RoboN plasmid or the plain vector followed by antibiotic selection and single Robo1.
To determine the functional significance of Robo1, we percell cloning. Using this approach, three stable single cell clones expressing RoboN (designated as RoboN/A375_C1, C2, and formed reconstitution experiments using Robo1/293 cells. Slit2 and bFGF both promoted the migration of Robo1/293 cells, but C3 cells) and one stable cell clone expressing the vector (designated as V/A375 cells) were generated. These clones were charRoboN only neutralized Slit2-induced, but not bFGF-induced, migration of Robo1/293 cells ( Figure 2C ). Furthermore, bFGF, acterized by immunoblotting for RoboN, Slit2, and VEGF (␤-tubulin as loading control) expression to ensure that the simibut not Slit2, triggered the migration of V/293 cells, indicating that HEK293 cells express endogenous receptors for bFGF. lar amounts of RoboN were expressed in all three C1, C2, and C3 clones and that no alterations of Slit2 and VEGF expression Evidently, Robo1 is essential for the cell migration mediated by Slit2, but not mediated by bFGF, suggesting a specific role for were detected among RoboN/A375_C1, C2, C3, and V/A375 clones ( Figure 3A ). In addition, they were tested for in vitro Robo1 in mediating cellular responses to Slit2.
To determine whether Slit2 guided the direction of endothegrowth rates to ensure that they all grew at similar rates in cell culture conditions ( Figure 3B ). lial cell migration, rather than simply increasing the motility (nondirectional or random migration) of endothelial cells, we adopted These transfectants were then inoculated subcutaneously into athymic nude mice. When compared to those from V/A375 a technique that had been successfully used for direct observation of axon projection (Song et al., 1997; Ming et al., 2002) . cells, tumors resulting from RoboN/A375_C1, C2, and C3 cells had significantly reduced microvessel densities (Figures 3C and This device could generate a microscopic gradient of a specific protein delivered in a picoliter volume through a micropipette 3D). Furthermore, the tumor volumes and masses from Robo1/ A375_C1, C2, and C3 cells were all markedly smaller than those by repetitive pressue (Hö pker et al., 1999) . We loaded a micropipette with Slit2 or bFGF protein and placed its tip at a distance from the control V/A375 (Figures 3E and 3F).
As an alternative approach to the RoboN construct, we of 100 m away from the center of individual HUVECs. The entire trajectory of the migrating HUVECs was recorded in a tested R5, the function-blocking monoclonal antibody against the first immunoglobulin motif of Robo1. RoboN would block timelapse microscopy. As shown in the examples ( Figure 2D ), the endothelial cell did not migrate when PBS (phosphate bufSlit signaling by absorbing Slit proteins, whereas R5 should block Robo specifically, thereby providing a complementary fered saline, pH 7.4) was applied. However, it migrated toward the micropipette loaded with Slit2 in a time-dependent manner, approach to inhibit Slit2-Robo1 signaling. We found that, compared to an IgG 2b control, R5 clearly reduced tumor microvessel indicating that Slit2 was a chemoattractant for HUVECs. In contrast, HUVECs could migrate toward or away from the microdensities and tumor masses ( Figures 3H-3M ). To substantiate the above conclusion, we further examined pipette loaded with bFGF in a time-dependent manner (an example of a cell migrating away from bFGF was shown in Figure the effects of Slit2 overexpression in tumor angiogenesis and growth. We proposed that Slit2 overexpression could induce 2D). The entire sets of experimental data could be presented as the cumulative distribution (%) versus migrated distance (m; the exaggerated tumor angiogenesis and the accelerated expansion of tumor mass. After transfection of A375 cells with Figure 2E ) and, alternatively, as the migrated distance (m) versus the various treatment ( Figure 2F ). Cell migration toward a the Slit2 plasmid or the plain vector as described above, we generated two stable single cell clones expressing Slit2 (desigSlit2 gradient established an attractive role for the Slit2-induced endothelial cell migration ( Figures 2D-2F ). In contrast, bFGF nated as Slit2/A375_C1 and C2 cells) and one stable cell clone expressing the vector (designated as V/A375 cells). They were increased the motility of HUVECs by inducing the migration of HUVECs; however, this migration was not directional (Figures characterized by immunoblotting for Slit2 and VEGF (␤-tubulin as loading control) expression to ensure that the similar amounts Furthermore, the tumor volumes and masses from Slit2/A375_C1 and C2 cells were all significantly bigger than those from the of Slit2 were overexpressed in both C1 and C2 clones and that no alterations of VEGF expression were detected among C1, control V/A375 (Supplemental Figures S1E and S1F ). These in vivo results demonstrate the biological significance of Slit2-C2, and V/A375 clones (Supplemental Figure S1A at http:// www.cancercell.org/cgi/content/full/4/1/19/DC1). In addition, Robo1 signaling in tumor angiogenesis and growth. As endothelial cells expressed both Slit2 and Robo1 and they were tested to ensure that they all grew at similar rates in cell culture conditions (Supplemental Figure S1B) .
Slit2 reportedly inhibited leukocyte chemotaxis ), we measured the leukocyte counts in the blood and in the After inoculation of these transfectants, tumors resulting from Slit2/A375_C1 and C2 cells had significantly increased solid tumors of these xenografted mice. We found no clear differences among these groups ( Figures 3G and 3N and Supmicrovessel densities if compared to those from V/A375 cells (Supplemental Figures S1C and S1D on Cancer Cell website).
plemental Figure S1G ). The equivalent numbers of leukocytes salivary gland), and A673 cells (rhabdomyosarcoma; Figure 4A Figures 6A and 6B ). Both inhibitors also cDNA fragment ( Figure 4B) . Again, the ␤-tubulin immunoblotting attenuated directional migration ( Figure 6E ) and tubulogenesis and the G3PDH Northern blotting were used as the loading induced by Slit2 ( Figures 6C and 6D) . Biochemically, Slit2, but controls of input proteins and RNAs ( Figures 4A and 4B) . not bFGF, could activate PI-3K in HUVECs, resulting in the The finding of Slit2 expression in a variety of cancer cell increased radioactivity of 32 P-ATP-labeled inositol phospholiplines is consistent with the recent report of Slit2 expression in ids ( Figures 6F and 6G ). These data demonstrate that activation prostate cancers using a RT-PCR-based approach (Latil et al., of PI-3K in HUVECs by Slit2 is required for directional migration 2003). Along this line of investigation, we examined human samand tube formation of vascular endothelial cells. ples of malignant melanoma, rectal mucinous adenocarcinoma, invasive breast carcinoma, gastric squamous carcinoma, and hepatocellular carcinoma for Slit2 expression ( Figure 4C ). We found that in all these cancer samples, Slit2 was expressed in the cancerous tissues, but not in the nearby regions of apparently normal tissues. The positive staining of Slit2 was found in 3 malignant melanomas (n ϭ 7), 51 breast carcinomas (n ϭ 72; 70.8% positive), 42 colorectal carcinomas (n ϭ 65; 64.6% positive), and 38 gastric carcinomas (n ϭ 74; 51.4% positive). Notably, Slit2 staining appeared to be more intense in the areas of the tumor, where more cancer cells and blood vessels (visualized by an antibody to vWF) existed within human colon carcinoma ( Figure 5A ). In contrast, less Slit2 staining was detected where there were fewer cancer cells and vasculatures. A similar correlation was also found in human breast carcinoma (data not shown). Furthermore, Slit2 was absent in normal and hyperplastic colon tissues, began to appear in colon adenomas (3/14; 21.4% positive), and upregulated in colon carcinoma (42/65; 64.6% positive; Figure 5B ). These data suggest a correlation the Slit2-Robo1 signaling in vascular endothelial cells, we 
Discussion
mor-induced angiogenesis. Because we can inhibit tumor growth in vivo by specific neutralization of the Slit2-Robo1 interOur results have concluded that in addition to its well-characteraction with either the extracellular part of Robo1 or R5, the ized functions in axon guidance and neuronal migration, Slit2 function-blocking monoclonal antibody for Robo1, it not only can attract vascular endothelial cells and promote tumor-induced indicates the importance of Slit-Robo signaling in tumor-induced angiogenesis and tumor growth, but also provides novel molecangiogenesis. This strengthens the idea of fundamental conservation of guidance mechanisms for all somatic cells (Wu et ular tools for attenuating tumors. Taken together, our results have significant implications in both basic mechanisms and al., 2001; Rao et al., 2002) . Our results also indicate that Slit2 expressed in solid tumors can communicate with Robo1 exclinical applications. Migratory behavior is distinct among different cell types, pressed in endothelial cells, revealing a pathway mediating tu-with different speeds and different morphologies. Previously, Slits , which have not been tested in tumors. It is possible that Slit1 and Slit3 could also be expressed in distinct guidance cues have been found for different cells, with chemotactic factors functioning through seven transmembrane some tumors. Similarly, we have so far focused on Robo1, whereas there are three other Robos. Considering the possibility G protein-coupled receptors (GPCRs) discovered to be important for nonneuronal cells and guidance cues functioning through that different Robos could be involved in angiogenesis, we suspect that RoboN (made from the extracellular part of Robo1) single transmembrane receptors shown to be important for neurons. Only recently have neuronal guidance cues been found to may block all three Slits and that the R5 antibody (made by immunization of and screening against the first immunoglobulin directly guide the migration of leukocytes ) while leukocyte chemotactic factors were shown to function directly domain of Robo1) may block other Robos as well as Robo1. The result of immunohistochemical staining suggests that on neurons (Lu et al., 2001 (Lu et al., , 2002 Klein et al., 2001; Zhu et al., 2002; Xiang et al., 2002) . Those findings based on neurons Slit2 protein is expressed in a center-to-periphery gradient in and leukocytes led to the proposal of the idea of conserved solid tumors. It will be interesting to investigate whether this molecular mechanisms among all somatic cell types (Wu et al., gradient contributes to the exaggerated angiogenesis in the 2001; Rao et al., 2002) . Results reported in the present study center of solid tumors and what is the mechanism for forming significantly strengthen the idea by extending the conservation and maintaining the Slit2 gradient. It has been reported that to vascular endothelial cells and to pathological processes.
Slit2 associates with HSPGs on Glypican-1 expressed on the All previous studies of Slits in neurons and leukocytes indineuronal cells in the central nervous system. Likewise, the gradicate that Slits are repulsive or inhibitory for migrating cells (reent formation of Hedgehog requires Tout-velu, an enzyme incently reviewed in Wong et al., 2002) . It is thus curious that Slit2 volved in HSPG biosynthesis (Bellaiche and Perrimon, 1998). has been found to function as a chemoattractant for vascular Further, overexpression of the glypican HSPG, called Dally-like, endothelial cells. Previous studies by Poo and colleagues have leads to higher than normal levels of extracellular Wingless (Wg) shown that the same guidance cue can either attract or repel accumulation (Tsuda et al., 1999) . In contrast, clones defective the same axons depending on intracellular cAMP and cGMP in HSPG biosyhthesis bind to lower than normal levels of extralevels (Song et al., 1997) . It will be interesting to test whether cellular Wg and are deficient in Wg signaling (Baeg et al., 2001 ). cAMP and cGMP play a role in endothelial cell migration and Notum, a member of the ␣/␤-hydrolase superfamily, influences angiogenesis, in addition to their roles in endothelial responses the distribution of Wg by modifying HSPG Dally-like and Dally to Slit2.
(Girá dex et al., 2002). Our finding that pretreatment of A375 We have found that PI-3K is involved in endothelial cell cells with heparin increases the amount of Slit2 in the supernaresponses to Slit2. It will be interesting to compare the pathways tants and, at the same time, decreases the amount of Slit2 in mediating attractive responses in endothelial cells to those in the whole cell lysates also supports the association of Slit2 with neurons, although the intracellular transduction pathway for SlitHSPGs on cancer cells. It remains to be determined whether Robo signaling in neuronal repulsion is only beginning to emerge Slit2 is associated with Glypican-1 HSPGs expressed on cancer (Bashaw et al., 2000; Fritz and VanBerkum, 2000; Wong et al., cells, whether regulation of Glypican-1 HSPGs alters the tempo-2001). For example, it would be interesting to know whether ral and spatial distribution of Slit2 on cancer solids, and whether PI-3K inhibitors, such as Wortmannin and LY294002, could Tout-velu and/or Notum could affect the surface localization of prevent the repellant action of Slit2 on axon guidance and neuSlit2 by modulating Glypican-1 HSPGs. ronal migration, and the inhibitory action of Slit2 on leukocyte
The results presented here have demonstrated the role of chemotaxis.
Slit2-Robo1 signaling in tumor angiogenesis and have evaluated Extensive studies of genetically engineered mouse models the significance of this signaling pathway in the pathogenesis of spontaneous tumorigenesis and pathological examinations of cancers. However, whether this discovery can be translated of human cancers have delineated discrete stages of carcinoto the diagnosis, treatment, and prevention of malignant tumors genesis, including pre-angiogenic hyperplasia/dysplasia/carciremains to be determined. For example, can the immunohistonoma in situ (CIS), angiogenic dysplasia/CIS, and small tumor chemical staining of Slit2 be used as a reliable marker for the and large tumor/invasive carcinoma (Hanahan and Folkman, diagnosis of certain cancers? Are the measurements of Slit2 in 1996). Among these stages, angiogenesis is switched on during the blood and the urine useful for screening certain carcinomas? the premalignant stage of tumor development, persisting thereConsidering that the neutralization of Robo1 activity incomafter. Although VEGF-mediated signaling is generally believed pletely reduces the microvessel density and the tumor mass of to be essential for the angiogenic switch, the expression of VEGF malignant melanoma (Figure 3 ), it will be interesting to test the and its cognate receptors, flt-1 (VEGF-R1) and flk-1 (VEGF-R2), efficacy of a combined therapy using inhibitors for both VEGF appears to be constitutive; no alterations in the expression of and Slit2 for treatment of cancers. It is also interesting to test these molecules can be clearly detected whether Slit2 has any synergistic effects on the angiogenic activ-2000; Inoue et al., 2002) . The disappointing results from the ities of VEGF, FGF, ephrin, and other known angiogenic factors. clinical trial using several inhibitors for VEGF and its receptors are consistent with the notion that other angiogenic factors are (Kerbel and Folkman, 2002) . Our finding of the Slit2 expression Primary HUVECs were cultured as previously described (Geng et al., 1990). on cancerous tissues ( Figure 5B ) suggests that Slit2 is a novel RT-PCR was performed as before (Ma and Geng, 2000) . Primers used were player in tumorigenesis.
human SLIT2 sense (ϩ3611) 5Ј-GGT GAC GGA TCC CAT ATC GCG GTA It should be pointed out that we have screened and found GAA CTC-3Ј and antisense (Ϫ4574) 5Ј-GGA CAC CTC GAG CGT ACA GCC the increased Slit2 expression in a number of tumor cell lines GCA CTT CAC-3Ј; human ROBO1 sense (ϩ4440) 5Ј-CCT ACA CAG ATG ATC TTC C-3Ј and antisense (Ϫ4956) 5Ј-CAG AGG AGC CTG CAG CTC and primary tumors in this study. However, there are two other AGC TTT CAG TTT CCT C-3Ј; human ␤-ACTIN sense (ϩ1) 5Ј-ATG GAT GAT Tube formation assay 96-well cell culture plates were coated with 100 l/well of Matrigel and GAT ATC GCC GC-3Ј and antisense (Ϫ1127) 5Ј-CTA GAA GCA TTT GCG GTG G-3Ј. Total RNAs from A375 cells and the primary culture of HUVECs incubated at 37ЊC for 30 min to promote gelling (Malinda et al., 1999 , 1999, 2001) .
Lipofectin (Gibco) and selected by 400 g/ml hygromycin B (Sigma). The stable single cell clones of RoboN/A375_C1, C2, and C3 cells, Slit2/A375_C1 Antibody generation, immunoblotting, and immunostaining and C2 cells as well as V/A375 cells were verified by immunoblotting with GST and His-tag fusion proteins of Slit2 (encoding 57-207 or 1272-1593 antibodies against Robo1, Slit2, VEGF, and ␤-tubulin (as the loading control). amino acids of human Slit2) and Robo1 (encoding 1-168 or 961-1217 amino They were resuspended at 5 ϫ 10 6 cells/ml and an aliquot of 0.2 ml cell acids of rat Robo1) were constructed into pGEX-4T-1 (Amersham Pharmacia suspension was injected subcutaneously into athymic nude mice (O'Reilly Biotech) and pET-30a(ϩ) (Novagen) vectors and expressed according to the et al., 1997). For antibody inhibition experiments, mice bearing A375 cell manufacturers' protocols. The purified GST fusion proteins were used as tumors were treated with intraperitoneal injections of R5 or an IgG 2b control the antigens to immunize rabbits and mice for generation of anti-Slit2 and twice per week (1 mg per injection). Tumor volumes were determined by anti-Robo1 polyclonal and monoclonal antibodies. The purified His-tag fuexternal measurements and calculated according to the equation, V ϭ [L ϫ sion proteins were used for affinity isolation of the polyclonal antibodies W 2 ] ϫ 0.52 (V ϭ volume, L ϭ length, and W ϭ width). Mice were sacrificed and for ELISA assay during the screening of monoclonal antibodies. Equal 28-35 days later. Mouse blood was collected before sacrifice for leukocyte amounts of cell lysates (routinely verified by ␤-tubulin immunoblotting; counts, and myeloperoxidase activity for quantification of neutrophils within Sigma) were used for immunoblotting. For experiments of TNF-␣ or heparin the tumors was performed (Wang et al., 2002) . treatment, A375 cells were cultured in the presence of either 300 units/ ml TNF-␣, 50 g/ml heparin, or both for 12 hr. Antibodies against CD31
Cell proliferation assay (PharMingen; a 1:50 dilution for cryostat sections), vWF (Antibody DiagnosAll transfectants were grown in exponential phase and detached by trypsin tica Inc.; a 1:200 dilution for paraffin-embedding and cryostat sections), Slit2 treatment. Viable cells (5 ϫ 10 4 cells/ml) were plated into 96-well tissue (5 g/ml for paraffin-embedding sections), and Robo1 (20 g/ml for cryostat culture plates (100 l complete medium/well) and cultured at 37ЊC in 5% sections) were used for immunohistochemical staining, as described before CO 2 atmosphere. At different time points, tetrazolium salt was added (20 (Liu et al., 2001) .
l/well) and incubated at 37ЊC for 4 hr. The insoluble blue formazan product was solubilized by addition of 100 l/well 10% SDS/5% isobutanol. The Isolation of Slit2 and RoboN plates were read on a microtiter plate reader using a test wavelength of 570 Recombinant Slit2 and RoboN proteins were purified from the conditioned nm and a reference wavelength of 630 nm. medium by affinity chromatography using a 9E10 mAb to the c-myc tag ‫1ف(‬ mg/ml Affi-Gel 10; Bio-Rad) or a HA11 mAb to HA, HA11 (BAbCO). Purified
Measurements of PI-3K activity Slit2 was silver stained and immunoblotted as before (Geng et al., 1997) .
PI-3K activity assay was carried out as described before (Wallasch et al., 1995) . HUVECs were starved in a M199 medium containing 2% FCS for 2 Boyden chamber assay hr and then stimulated with 10 ng/ml Slit2 at 22ЊC for 15 min. The cell migration assay (Gho et al., 1999) was conducted in a 48-well microchemotaxis chamber (Neuro Probe, Inc.). PVP-free polycarbonate memAcknowledgments branes (8 m pores) were coated with 1% gelatin. The bottom chambers were loaded with or without Slit2 or bFGF (Sigma), while the upper chambers
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Directional migration assay
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The microscopic gradients of proteins were produced as described (Hö pker Published: July 21, 2003 July 21, et al., 1999 . Briefly, a repetitive pressure injection of picoliter volumes of 0.15 M Slit2 or 1 M bFGF was applied through a micropipette with a tip References at the opening of ‫1ف‬ m. The 24-well culture plate was coated with a thin layer of Matrigel (Becton Dickinson Labware) and the test cells were allowed to settle and to loosely attach to Matrigel. The experiments were carried out Baeg, G.H., Lin, X., Khare, N., Baumgartner, S., and Perrimon, N. (2001) . at 37ЊC in the presence of 5% CO 2 . The pipette tip was placed 100 m Heparan sulfate proteoglycans are critical for the organization of the extracelaway from the center of any given cell under testing. Bellaiche, Y., and Perrimon, N. (1998). Tout-velu is a Drosophila homologue
